15-04-2024
|
|
|
Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
09-04-2024
|
|
|
Mangalam Drugs And Organics Limitedï¿‚ï¾ has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaï¿‚ï¾ (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 |
|
|
|
02-04-2024
|
|
|
Mangalam Drugs And Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
02-04-2024
|
|
|
MANGALAM DRUGS AND ORGANICS LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
20-03-2024
|
|
|
Mangalam Drugs and Organics Limited has informed the Exchange regarding Amalgamation/ Merger |
|
|
|
19-03-2024
|
|
|
Mangalam Drugs and Organics Limited has informed the Exchange regarding Amalgamation/ Merger |
|
|
|
15-02-2024
|
|
|
Mangalam Drugs And Organics Limited has informed the Exchange about Copy of Newspaper Publication |
|
|
|
14-02-2024
|
|
|
Mangalam Drugs And Organics Limited has informed the Exchange about Copy of Newspaper Publication |
|
|
|
14-02-2024
|
|
|
Mangalam Drugs And Organics Limited has submitted to the Exchange, the financial results for the period ended December 31, 2023. |
|
|
|
07-02-2024
|
|
|
MANGALAM DRUGS AND ORGANICS LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . |
|
|
|
|
|